Skip to content

Regional Ventilation During High Flow Nasal Cannula and Conventional Nasal Cannula in Patients With Hypoxia

Comparison of Regional Ventilation Pattern During High Flow Nasal Cannula Between Conventional Low Flow System Nasal Cannula in Patients With Mild to Moderate Hypoxia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02943863
Enrollment
24
Registered
2016-10-25
Start date
2014-09-30
Completion date
2015-02-28
Last updated
2016-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Flow Nasal Cannula, Hypoxia, Oxygen Therapy, Ventilation

Brief summary

High-flow nasal cannula (HFNC) that uses heated and humidified oxygen was recently introduced for bedside care. It has been shown to be associated with reduced risks of tracheal intubation rates and mortality in adult hypoxic patients. The mechanisms of the effects of HFNC are thought to be related to the favorable effects of the heated and humidified gas, the high-flow rate used to minimize the entrainment of room air, and an increase in the ventilation efficiency, including the elimination of nasopharyngeal dead space, positive end-expiratory pressure (PEEP) effects, and improvements in paradoxical abdominal movement. Regarding the effects on lung volume, global ventilation in the lungs increases during HFNC, which is thought to attribute to PEEP effects. However, how regional ventilation is affected during HFNC in comparison with conventional NC remains unknown. Because PEEP in mechanically ventilated patients improves the regional homogeneity of ventilation, investigators postulated that HFNC via PEEP effects would result in more homogeneous regional distributions in the ventilation changes. Investigators therefore assessed global and regional ventilation in patients with hypoxia receiving care via HFNC using electric impedance tomography and compared these results with conventional nasal cannula.

Interventions

DEVICEHFNC followed by conventional nasal cannula
DEVICEConventional nasal cannula followed by HFNC

Sponsors

Ministry of Trade, Industry & Energy, Republic of Korea
CollaboratorOTHER_GOV
Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>20 years * Subjective dyspnea in room air * SaO2\< 90% in room air * Oxygen requirement for nasal cannula \< 6 L/m

Exclusion criteria

* Unstable vital signs * SBP \<90 mmHg * DBP \< 60 mmHg * Heart rate \> 120 bpm * Respiratory rate \> 30 bpm * Persistent dyspnea under oxygen therapy using NC * Severe hypoxia * PaO2/FiO2\< 200 mmHg * Unable to cooperate * Delirium * Reduced cognitive function

Design outcomes

Primary

MeasureTime frameDescription
Tidal variationTwenty minutes after each oxygen therapy. (At the end of each oxygen therapy)Tidal variation using electric impedance tomography

Secondary

MeasureTime frameDescription
Oxygen saturationTwenty minutes after each oxygen therapy. (At the end of each oxygen therapy)Oxygen saturation at using pulse oxymeter
Respiration RateTwenty minutes after each oxygen therapy. (At the end of each oxygen therapy)
Subjective comfortTwenty minutes after each oxygen therapy. (At the end of each oxygen therapy)Subjective comfort using questionnaire

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026